| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |